SYNTAX score subgroups demonstrated numerically higher MACE rates in patients with PES compared to EES (15.3% vs. 5.1%) and (30.0% vs. 15.4%) respectively.
Results:
The mean age of the cohort was 49.0 ± 9.4 years and 94% were men. At baseline, coronary risk factors were well balanced and angiographic features were not different between both groups. MACCE at 3-year are depicted in Table. The rate of occurrence of first MACCE at 36-months was similar in both groups (uivariate hazard ratio [HR]=1.4, 95% CI, 0.7-2.6). However, recurrent ACS was more frequent in HIV+ group as compared with 95% CI, . Stratified multivariate Cox model showed that the only factor associated with the recurrence of ACS was HIV status with HR 7.86 for HIV+ versus HIV-(95% CI, 1.2-50.6, p= 0.03).
Conclusion:
HIV-infected patients had higher recurrence of ACS despite similar coronary risk factors, clinical, and angiographic features at baseline of a first episode of ACS as compared to HIV-uninfected patients. Specific secondary prevention may be warranted to alleviate this risk. Purpose: Our aim was to assess the long term prognosis value of resting HR in a contemporary large cohort of subjects with known CAD.
Methods: Among 834 consecutive male pts hospitalized in 2001-2004 for coronary artery disease, HR was measured in 778 pts. The median follow-up was 7.17 years. Total mortality was predicted with a Cox proportional hazard model Results: Mean age (SD) was 60.2 (8.1), 144 pts (18.4%) were diabetic, mean glycaemia was 5.9 mmol/l (2.1), 155 pts (19.8%) were smokers, mean blood pressure was 139 (20) / 84 (11) mmHg. Mean HDL cholesterol was 43 mg/dl (11), mean LDL cholesterol124 mg/dl (39) and median triglycerides were 147 mg/dl IQR . Mean Cockcroft-Gault creatinine clearance was 87 ml/min and 11 pts (1.4%) had a severe chronic renal failure (lower than 30 ml/min). Mean left ventricular ejection fraction was 0.53 (0.13). 88.5% were on antiplatelet therapy, 75.2% on beta-blocker, 66% on statin therapy and 54.8% on ACE inhibitors or ARB. 40.5% of pts had HR < 60 bpm, 32% HR between 60 and 69 bpm and 27.5% had HR t70 bpm. The cumulative seven-year total mortality rate was 17.8%. In the HR < 60 bpm group, mortality rate was 11.1%, whereas it was 17.3% in the group with HR -60 bpm and < 70 bpm and 28.5% in the HR t70 bpm group (p<.001).
We performed a multivariate analysis adjusted for age, diabetes, tobacco consumption (none; d40 pack-years; > 40 pack-years), left ventricular ejection fraction (>0.5; d0.5 and > 0.35; d0.35), duration of CAD, ankle-brachial index (> 0.9; d0.9 and > 0.6; d0.6), history of chronic obstructive pulmonary disease or stroke, statin therapy and coronary revascularization. For every 5 bpm increase in resting heart rate, there was a significant 11% increase in all-cause death (95% CI [4%; 18%] p=0.002).
HR is a strong and independent long term predictor factor of all-cause death in CAD. A close control of HR should be promoted to improve long term prognosis in coronary pts.
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